Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Cardiol ; 33(2): 295-301, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21968577

ABSTRACT

Stress myocardial perfusion scintigraphy imaging (SMPSI) has important applications for evaluating coronary disease and ventricular function. Studies consistently focus on the left ventricle (LV), with no normal right ventricle (RV) data available. This study sought to evaluate the feasibility of RV perfusion with technetium (Tc-99m) sestamibi using a low radiotracer dose for children free of coronary artery (CA) anomalies and to determine its normal pattern. Patients with a history of Kawasaki disease who showed no coronary complications on selective angiography or no LV perfusion defects on SMPSI were studied at rest and during an exercise challenge. The RV uptake counts were compared with those for different segments of the LV, and multiple ratios of the uptakes between RV and LV segments were calculated. The study subjects were 23 children (age, 11.1 ± 3.3 years) imaged with 0.12 ± 0.03 mCi/kg at rest and 0.31 ± 0.06 mCi/kg during stress. The RV to LV uptake proportion was approximately 6%. Exercise-related uptake increased threefold in both the RV and the LV. The findings showed RV myocardial scintigraphy to be feasible with reproducible ratios. Potential clinical applications include acquired and congenital CA anomalies such as Kawasaki disease, right CA ostium stenosis after a switch operation, and anomalous origin of the right CA.


Subject(s)
Heart Ventricles/diagnostic imaging , Mucocutaneous Lymph Node Syndrome/diagnostic imaging , Myocardial Perfusion Imaging , Child , Child, Preschool , Exercise Test , Feasibility Studies , Female , Heart Ventricles/physiopathology , Humans , Male , Mucocutaneous Lymph Node Syndrome/complications , Radiopharmaceuticals , Technetium Tc 99m Sestamibi
SELECTION OF CITATIONS
SEARCH DETAIL
...